You might also like
Logility Supply Chain Solutions, Inc. (LGTY) is a software company headquartered in Atlanta, Georgia, specializing in supply chain planning solutions. The company offers a range of products and services designed to optimize supply chain operations, including software subscriptions, licenses, professional services, and maintenance agreements. Its primary focus is on providing tools that enhance supply chain efficiency and decision-making for businesses.
- Supply Chain Management (SCM) - Provides subscription-based software solutions, licenses, and professional services for supply chain planning, including implementation, training, and consulting. Revenue is primarily derived from subscription fees, maintenance agreements, and professional services.
- Other - Includes revenue from non-core activities, contributing a smaller portion to the company's overall operations.
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
Garvis AI Limited | 2023 | Completed on September 5, 2023, the acquisition was executed for $25.0 million net of cash, including key assets such as current technology (valued at approximately $9.0 million), non-compete agreements, and approximately $16.2–$16.9 million in goodwill. The deal is strategically aimed at enhancing Logility’s Digital Supply Chain Platform with its AI-native demand forecasting solution, DemandAI+. |
Starboard Solutions Corp. | 2022 | Effective June 28, 2022, this acquisition was structured for approximately $6.5 million in cash with an earnout potential of up to $6.0 million over three years. It involved the purchase of assets such as goodwill, current technology, customer relationships, and non-compete agreements, which together bolster Logility’s supply chain network design capabilities and integrate a digital twin into its platform. |
Recent developments and announcements about LGTY.
8-K Filings
8-K Filing
·1 day agoOther EventsView full 8-K filing →The 8-K filing notes that the HSR waiting period expired on March 10, 2025, fulfilling a key condition for the merger with Aptean. Pending UK, shareholder, and other customary approvals, the acquisition is expected to close in Q2 2025.